Skip to main content
. 2022 Apr 30;41:159. doi: 10.1186/s13046-022-02363-9

Fig. 6.

Fig. 6

CDC20 alterations across hemato-oncological patients. A Frequency and distribution of CDC20 mutations and copy number alterations (CAN) in hematological malignancies. B Effect of CNA on CDC20 mRNA level in AML and DLBCL cases